Original Source(s)
Related Content
FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.
June 15, 2026
-
3 min
FDA guidance spurs adoption of change control plans for radiology AI devices
Investigators examined adoption and public documentation of change control plans for FDA-cleared radiology AI devices.
September 16, 2026
-
3 min